Evidence map›Paper›PMID 23699517›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

PI3K-Akt signaling activates mTOR-mediated epileptogenesis in organotypic hippocampal culture model of post-traumatic epilepsy.

Yevgeny Berdichevsky, Alexandra M Dryer, Yero Saponjian, Mark M Mahoney, Corrin A Pimentel, Corrina A Lucini, Marija Usenovic, Kevin J Staley

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The functional and molecular roles of p75 neurotrophin receptor (p75Journal of central nervous system disease · 2024
    Review
  8. International journal of molecular sciences · 2023
    Article
  9. A Dynamic Balance between Neuronal Death and Clearance in anThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yevgeny BerdichevskyDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02129, USA.
Alexandra M Dryer
Yero Saponjian
Mark M Mahoney
Corrin A Pimentel
Corrina A Lucini
Marija Usenovic
Kevin J Staley
Lehigh University · USHarvard University · USMassachusetts General Hospital · US

Funding

LINKING SYNAPTIC PROPERTIES TO NEURAL NETWORK OPERATIONR01NS034700 · NINDS · UNIVERSITY OF COLORADO DENVER · PI STALEY, KEVIN J. · 1999 to 2020
$7.7M
Positive Feedback in Epileptic NetworksR01NS034360 · NINDS · UNIVERSITY OF COLORADO DENVER · PI STALEY, KEVIN J. · 1997 to 2008
$3.1M
Optimizing Organotypic Slices to Study EpileptogenesisR01NS077908 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI STALEY, KEVIN J. · 2011 to 2014
$1.7M
Moderate-throughput screening for anti-epileptogenic drugs.R21NS072258 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI STALEY, KEVIN J. · 2011 to 2012
$470k
NINDS NIH HHS R01 NS034360NINDS NIH HHS R01 NS034700NINDS NIH HHS R01 NS077908NINDS NIH HHS R21 NS072258
6 · The paper itself

Abstract

mTOR is activated in epilepsy, but the mechanisms of mTOR activation in post-traumatic epileptogenesis are unknown. It is also not clear whether mTOR inhibition has an anti-epileptogenic, or merely anticonvulsive effect. The rat hippocampal organotypic culture model of post-traumatic epilepsy was used to study the effects of long-term (four weeks) inhibition of signaling pathways that interact with mTOR. Ictal activity was quantified by measurement of lactate production and electrical recordings, and cell death was quantified with lactate dehydrogenase (LDH) release measurements and Nissl-stained neuron counts. Lactate and LDH measurements were well correlated with electrographic activity and neuron counts, respectively. Inhibition of PI3K and Akt prevented activation of mTOR, and was as effective as inhibition of mTOR in reducing ictal activity and cell death. A dual inhibitor of PI3K and mTOR, NVP-BEZ235, was also effective. Inhibition of mTOR with rapamycin reduced axon sprouting. Late start of rapamycin treatment was effective in reducing epileptic activity and cell death, while early termination of rapamycin treatment did not result in increased epileptic activity or cell death. The conclusions of the study are as follows: (1) the organotypic hippocampal culture model of post-traumatic epilepsy comprises a rapid assay of anti-epileptogenic and neuroprotective activities and, in this model (2) mTOR activation depends on PI3K-Akt signaling, and (3) transient inhibition of mTOR has sustained effects on epilepsy.

Indexed as

Analysis of VarianceAnimalsAnimals, NewbornAxonsCell DeathDose-Response Relationship, DrugEnzyme InhibitorsEvoked PotentialsExcitatory Amino Acid AntagonistsHippocampusKynurenic AcidLactic AcidL-Lactate Dehydrogenase (Cytochrome)MaleMicrotubule-Associated ProteinsNeuronsEnzyme InhibitorsExcitatory Amino Acid AntagonistsKynurenic AcidLactic AcidL-Lactate Dehydrogenase (Cytochrome)Microtubule-Associated ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID23699517
PMCPMC3735438
OpenAlexW2082087902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.